Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,732 | 24,867 | 34,258 | 29,107 | 41,471 |
| Marketable Securities | 227,311 | 132,070 | 139,553 | 164,429 | 176,609 |
| Receivables | 3,374 | 2,944 | 2,903 | 2,987 | 2,430 |
| TOTAL | $282,780 | $165,322 | $183,460 | $200,806 | $222,502 |
| Non-Current Assets | |||||
| PPE Net | 1,830 | 1,931 | 2,048 | 2,079 | 557 |
| Intangibles | 41,638 | 41,638 | 41,638 | 41,638 | 41,638 |
| Other Non-Current Assets | 13,659 | 14,454 | 14,365 | 14,724 | 3,348 |
| TOTAL | $57,127 | $58,023 | $58,051 | $58,441 | $45,543 |
| Total Assets | $339,907 | $223,345 | $241,511 | $259,247 | $268,045 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,731 | 2,709 | 3,414 | 2,427 | 3,693 |
| Accrued Expenses | 13,112 | 9,430 | 7,585 | 10,141 | 9,679 |
| TOTAL | $24,440 | $21,498 | $19,935 | $25,205 | $18,472 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,411 | 6,151 | 6,082 | 9,933 | 5,100 |
| Other Non-Current Liabilities | 9,082 | 9,839 | 10,035 | 10,521 | 0 |
| TOTAL | $42,250 | $45,358 | $46,869 | $43,641 | $38,920 |
| Total Liabilities | $66,690 | $66,856 | $66,804 | $68,846 | $57,392 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,718 | 2,170 | 2,142 | 2,133 | 2,128 |
| Common Shares | 32 | 26 | 26 | 26 | 25 |
| Retained earnings | -439,421 | -412,337 | -387,342 | -368,839 | -341,787 |
| Other shareholders' equity | -201 | -205 | -187 | -239 | -347 |
| TOTAL | $273,217 | $156,489 | $174,707 | $190,401 | $210,653 |
| Total Liabilities And Equity | $339,907 | $223,345 | $241,511 | $259,247 | $268,045 |